CBD Is More Accepted Worldwide
CBD is slowly but surely becoming more accepted by the community. This is because the WHO (World Health Organization) has assessed cannabinoids, which has led to increased efforts worldwide.
Of course, there are several reviews on medicinal cannabis, but not from such a large and reliable source as the WHO. This assessment can open many doors around accessibility and research into medicinal cannabis. In this way, CBD can be removed from the list of ‘controversial substances’, which in turn makes it possible to carry out better research, to establish good regulations and to broaden direct access to the mainstream market. There has not yet been a spokesman for the WHO to go into more detail, but this will be discussed in the future.
The image of CBD and the legislation for medicinal cannabis worldwide is extremely diverse. In Europe, for example, there are a few places where you can buy cannabis legally, which means that Europe is relatively behind in terms of laws when it comes to other parts of the world. This is not a deliberate choice to prevent progressive research, but rather an outcome of all the different countries with their own vision. All these countries have their own views and all have to be considered before there is a unanimous decision on medicinal cannabis.
However, an advantage of countries that are lagging behind in terms of cannabis legislation is that they can first look at countries outside the EU or at neighbouring countries to see how things are going there. This makes it possible to take into account the views of the other countries. What works and what doesn’t, what is safe and what deserves thorough research. A country that is often raised for its progressive approach is Israel.
Israel – medicinal cannabis
Israel has been at the forefront of research into medicinal cannabis for quite some time now.
Medicinal cannabis has been permitted here since the 1990s, so it is no surprise that Israel has a great deal of knowledge. An important person for discovering the endocannabinoid system is Raphael Mechoulam. His workplace, the Centre for Pain Research in Jerusalem, is also the first research centre to have isolated the cannabinoids THC and CBD. The fact that Israel is one of the most progressive countries in the field of medicinal cannabis is now clear, but how is this possible? Israel owes this to the involvement of their government, which sponsors the clinical trials and trials for the majority. In fact, the Israel military uses medicinal cannabis for post-traumatic stress disorders (PTSD), which is common in the military.
In 2017, more than 110 clinical trials were conducted. Several disorders were investigated.
These include Parkinson’s disease, multiple sclerosis (MS), Crohn’s disease and many other forms of chronic pain. Israel’s goal is to remain dominant in the field of medical cannabis research. The Breath of Life research centre wants to build a 90,000-square-metre grow house to make these studies even more efficient, and Breath of Life also wants to become one of the most extensive research and development facilities in the world.
Increase in medicinal cannabis in Israel
The future of medical cannabis research is firmly in Israel’s grasp. That’s why we’re going into this in more detail now. In the link below you can read more about the research that the pioneering country is currently doing. Each study is at a different stage if you look at the effectiveness of cannabis as a treatment method, but this is promising as the plant needs to demonstrate as many appropriate ways to use it for medication as possible. The following studies will be discussed:
- Inflammatory bowel disease (IBD) and cancer
- Parkinson’s disease and insomnia
- Autism, epilepsy, bone fractures and diabetes
- Pain, PTSD and asthma
- Gilles de la Tourette and sleep apnea
Click here to learn more about the above studies.
Share this on Facebook
